Optimal medical therapy at discharge in patients with acute coronary syndromes: Temporal changes, characteristics, and 1-year outcome

American Heart Journal

Volumn 154, Issue 6, 2007, Pages 1108-1115

  Yan, Andrew T ^a,e   Yan, Raymond T ^a,e   Tan, Mary ^a,e   Huynh, Thao ^b,e   Soghrati, Kamyar ^a,e   Brunner, Lawrence J ^c,e   DeYoung, Paul ^d,e   Fitchett, David H ^a,e   Langer, Anatoly ^a,e   Goodman, Shaun G ^a,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Hotel Dieu Hospital   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TICLOPIDINE; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS SURGERY; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; ANTILIPEMIC AGENTS; CANADA; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBSERVATION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; REGISTRIES;

EID: 36248953709     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.07.040     Document Type: Article

References (34)

1. Tu J.V., Naylor C.D., and Austin P. Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ 161 (1999) 1257-1261
2. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 106 (2002) 1883-1890
3. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Can J Cardiol 20 (2004) 977-1025
4. Barron H.V., Michaels A.D., Maynard C., et al. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol 32 (1998) 360-367
5. Roe M.T., Peterson E.D., Newby L.K., et al. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 151 (2006) 1205-1213
6. Granger C.B., Steg P.G., Peterson E., et al. Medication performance measures and mortality following acute coronary syndromes. Am J Med 118 (2005) 858-865
7. Eagle K.A., Kline-Rogers E., Goodman S.G., et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 117 (2004) 73-81
8. Beck C.A., Lauzon C., Eisenberg M.J., et al. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec. Can J Cardiol 17 (2001) 33-40
9. Jackevicius C.A., Mamdani M., and Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288 (2002) 462-467
10. Blackburn D.F., Dobson R.T., Blackburn J.L., et al. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol 21 (2005) 485-488
11. Ho P.M., Spertus J.A., Masoudi F.A., et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 166 (2006) 1842-1847
12. Gislason G.H., Rasmussen J.N., Abildstrom S.Z., et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 27 (2006) 1153-1158
13. Pilote L., Beck C.A., Karp I., et al. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000. Can J Cardiol 20 (2004) 61-67
14. Spencer F.A., Lessard D., Yarzebski J., et al. Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Am Heart J 150 (2005) 838-844
15. Allen L.A., O'Donnell C.J., Giugliano R.P., et al. Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol 93 (2004) 1218-1222
16. Mukherjee D., Fang J., Chetcuti S., et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 109 (2004) 745-749
17. Yan A.T., Tan M., Fitchett D., et al. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 94 (2004) 25-29
18. Wiviott S.D., Cannon C.P., Morrow D.A., et al. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 46 (2005) 1411-1416
19. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
20. Yan A.T., Yan R.T., Tan M., et al. Contemporary management of dyslipidemia in high-risk patients: targets still not met. Am J Med 119 (2006) 676-683
21. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 163 (2003) 2345-2353
22. Yan A.T., Jong P., Yan R.T., et al. Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndromes. Am Heart J 148 (2004) 1020-1027
23. Yan A.T., Yan R.T., Tan M., et al. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J 28 (2007) 1072-1078
24. Eagle K.A., Lim M.J., Dabbous O.H., et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291 (2004) 2727-2733
25. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
26. Peterson E.D., Roe M.T., Mulgund J., et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 295 (2006) 1912-1920
27. Blomkalns A.L., Chen A.Y., Hochman J.S., et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 45 (2005) 832-837
28. Krumholz H.M., Radford M.J., Wang Y., et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 280 (1998) 623-629
29. Yan R.T., Yan A.T., Tan M., et al. Age-related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J 151 (2006) 352-359
30. Ray K.K., Bach R.G., Cannon C.P., et al. Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS. Eur Heart J 27 (2006) 2310-2316
31. Shepherd J., Blauw G.J., Murphy M.B., et al. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
32. McPherson R., Frohlich J., Fodor G., et al. Canadian Cardiovascular Society position statement-recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 22 (2006) 913-927
33. Mehta R.H., Montoye C.K., Faul J., et al. Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use: the American College of Cardiology Acute Myocardial Infarction Guidelines Applied in Practice Project in Michigan: Flint and Saginaw Expansion. J Am Coll Cardiol 43 (2004) 2166-2173
34. Heidenreich P.A. Patient adherence: the next frontier in quality improvement. Am J Med 117 (2004) 130-132